The preset invention relates to {HEAD ~ a biomarker} for identifying the subgroup of early stage lung adenocarcinoma patients in early stage non small cell lung cancer , which is T lymphokine activated killer cell originated {TAIL ~ protein kinase} , and a therapeutic target for lung cancer 
The preset invention relates to { HEAD ~ a biomarker } for identifying the subgroup of early stage lung adenocarcinoma patients in early stage non small cell lung cancer , which is T lymphokine activated killer cell originated { TAIL ~ protein kinase } , and a therapeutic target for lung cancer
OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH